CHUN LI, PH.D.

Assistant Director for Education

Chun Li, Ph.D. is an Asso­ciate Pro­fes­sor of Epi­demi­ol­ogy and Bio­sta­tis­tics.  He has exten­sive expe­ri­ence in sta­tis­ti­cal genet­ics research and genetic data analy­sis.  He is cur­rently work­ing on devel­op­ing meth­ods for detect­ing somatic changes using next-generation sequenc­ing data.  He is also inter­ested in devel­op­ing meth­ods to effi­ciently mine elec­tronic med­ical records.  Active in col­lab­o­ra­tive research, he has been work­ing with inves­ti­ga­tors in var­i­ous fields such as can­cer epi­demi­ol­ogy, clin­i­cal phar­ma­col­ogy, oph­thal­mol­ogy, car­dio­vas­cu­lar dis­ease, autism, type 2 dia­betes, etc.  He has pub­lished in Nature Genet­ics, New Eng­land Jour­nal of Med­i­cine, Blood, Amer­i­can Jour­nal of Human Genet­ics, Bioinformatics, etc.

Affiliations

CWRUlogowTag240x120CC-logo

Recent Publications

  1. Gabriel, M, Shaw, B, Brazauskas, R, Chen, M, Margolis, DA, Sengelov, H, Dahlberg, A, Ahmed, IA, Delgado, D, Lazarus, HM et al.. Risk Factors for Subsequent Central Nervous System (CNS) Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant (HCT): a Study From the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol. Blood Marrow Transplant. 2017; : . PubMed PMID:28411175 .
  2. Li, C, Singh, B, Graves-Deal, R, Ma, H, Starchenko, A, Fry, WH, Lu, Y, Wang, Y, Bogatcheva, G, Khan, MP et al.. Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 2017; 114 (14): E2852-E2861. PubMed PMID:28320945 PubMed Central PMC5389279.
  3. Chen, C, Ge, S, Li, S, Wu, L, Liu, T, Li, C. The Effects of Dietary Calcium Supplements Alone or With Vitamin D on Cholesterol Metabolism: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Nurs 2016; : . PubMed PMID:27870724 .
  4. Shaver, TM, Lehmann, BD, Beeler, JS, Li, CI, Li, Z, Jin, H, Stricker, TP, Shyr, Y, Pietenpol, JA. Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies. Cancer Res. 2016; 76 (16): 4850-60. PubMed PMID:27231203 PubMed Central PMC4987189.
  5. Adefurin, A, Darghosian, L, Okafor, C, Kawai, V, Li, C, Shah, A, Wei, WQ, Kurnik, D, Stein, CM. Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction. Int. J. Cardiol. 2016; 215 : 482-6. PubMed PMID:27131769 PubMed Central PMC4879094.
  6. Chatterjee, M, Turner, DC, Felip, E, Lena, H, Cappuzzo, F, Horn, L, Garon, EB, Hui, R, Arkenau, HT, Gubens, MA et al.. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Ann. Oncol. 2016; 27 (7): 1291-8. PubMed PMID:27117531 .
  7. Hoffman, JD, van Grinsven, MJ, Li, C, Brantley, M Jr, McGrath, J, Agarwal, A, Scott, WK, Schwartz, SG, Kovach, J, Pericak-Vance, M et al.. Genetic Association Analysis of Drusen Progression. Invest. Ophthalmol. Vis. Sci. 2016; 57 (4): 2225-31. PubMed PMID:27116550 PubMed Central PMC4849854.
  8. Adefurin, A, Ghimire, LV, Kohli, U, Muszkat, M, Sofowora, GG, Li, C, Levinson, RT, Paranjape, SY, Stein, CM, Kurnik, D et al.. Genetic variation in the alpha1B-adrenergic receptor and vascular response. Pharmacogenomics J. 2016; : . PubMed PMID:27089938 PubMed Central PMC5071105.
  9. Sheng, Q, Zhao, S, Li, CI, Shyr, Y, Guo, Y. Practicability of detecting somatic point mutation from RNA high throughput sequencing data. Genomics 2016; 107 (5): 163-9. PubMed PMID:27046520 .
  10. Zhang, Y, Cai, Q, Shu, XO, Gao, YT, Li, C, Zheng, W, Long, J. Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients. J Mol Genet Med 2015; 9 (4): . PubMed PMID:26870154 PubMed Central PMC4747093.

Search PubMed